Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cytomegalovirus multiple sclerosis:

Cytomegalovirus: a culprit or protector in multiple sclerosis? Vanheusden M et al. Trends Mol Med. (2015)

Cytomegalovirus seropositivity is negatively associated with multiple sclerosis. Sundqvist E et al. Mult Scler. (2014)

Cytomegalovirus and multiple sclerosis risk. Pakpoor J et al. J Neurol. (2013)

Search results

Items: 1 to 20 of 192

1.

Primary cytomegalovirus infection in a patient with relapsing-remitting multiple sclerosis under treatment with alemtuzumab.

Eichau S, López Ruiz R, Castón Osorio JJ, Ramírez E, Domínguez-Mayoral A, Izquierdo G.

Neurologia. 2018 Jun 12. pii: S0213-4853(18)30118-X. doi: 10.1016/j.nrl.2018.03.015. [Epub ahead of print] English, Spanish. No abstract available.

2.

Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the 'hygiene hypothesis'?

Alari-Pahissa E, Moreira A, Zabalza A, Alvarez-Lafuente R, Munteis E, Vera A, Arroyo R, Alvarez-Cermeño JC, Villar LM, López-Botet M, Martínez-Rodríguez JE.

Eur J Neurol. 2018 Jul;25(7):925-933. doi: 10.1111/ene.13622. Epub 2018 Apr 15.

PMID:
29528545
3.

Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatment.

Barone S, Scannapieco S, Torti C, Filippelli E, Pisani V, Granata A, Console D, Demonte G, Tallarico T, Polidoro S, Quattrone A, Valentino P.

Mult Scler Relat Disord. 2018 Feb;20:6-8. doi: 10.1016/j.msard.2017.12.009. Epub 2017 Dec 18.

PMID:
29272733
4.

[Intracranial cystic lesions].

Ahlhelm F, Shariat K, Götschi S, Ulmer S.

Radiologe. 2018 Feb;58(2):120-131. doi: 10.1007/s00117-017-0322-z. Review. German.

PMID:
29143062
5.

MOG antibody-associated optic neuritis in the setting of acute CMV infection.

Rusescu BV, Diederich NJ, Tsobo C, Marignier R, Kerschen P.

J Neurol Sci. 2017 Nov 15;382:44-46. doi: 10.1016/j.jns.2017.09.011. Epub 2017 Sep 9. No abstract available.

6.

More evidence is needed to show any role of cytomegalovisrus and varicella zoster virus in pathogenesis of multiple sclerosis.

Badihian S, Manouchehri N, Badihian N.

J Neuroimmunol. 2017 Dec 15;313:123-124. doi: 10.1016/j.jneuroim.2017.09.006. Epub 2017 Sep 18. No abstract available.

PMID:
29030049
7.

Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study.

Langer-Gould A, Wu J, Lucas R, Smith J, Gonzales E, Amezcua L, Haraszti S, Chen LH, Quach H, James JA, Barcellos LF, Xiang AH.

Neurology. 2017 Sep 26;89(13):1330-1337. doi: 10.1212/WNL.0000000000004412. Epub 2017 Aug 30.

PMID:
28855411
8.

Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion.

Romania P, Cifaldi L, Pignoloni B, Starc N, D'Alicandro V, Melaiu O, Li Pira G, Giorda E, Carrozzo R, Bergvall M, Bergström T, Alfredsson L, Olsson T, Kockum I, Seppälä I, Lehtimäki T, Hurme MA, Hengel H, Santoni A, Cerboni C, Locatelli F, D'Amato M, Fruci D.

Cell Rep. 2017 Jul 25;20(4):846-853. doi: 10.1016/j.celrep.2017.06.084.

9.

Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.

Rolf L, Muris AH, Mathias A, Du Pasquier R, Koneczny I, Disanto G, Kuhle J, Ramagopalan S, Damoiseaux J, Smolders J, Hupperts R.

Mult Scler. 2017 Jul 1:1352458517722646. doi: 10.1177/1352458517722646. [Epub ahead of print]

PMID:
28731372
10.

Acute respiratory distress syndrome following alemtuzumab therapy for relapsing multiple sclerosis.

Yann K, Jackson F, Sharaf N, Mihalova T, Talbot P, Rog D, Pace A.

Mult Scler Relat Disord. 2017 May;14:1-3. doi: 10.1016/j.msard.2017.03.001. Epub 2017 Mar 12.

PMID:
28619423
11.

Cytomegalovirus and varicella zoster virus seropositivity of Iranian patients with multiple sclerosis: A population-based study.

Karampoor S, Zahednasab H, Ramagopalan S, Mehrpour M, Etemadifar M, Alsahebfosoul F, Keyvani H.

J Neuroimmunol. 2017 Aug 15;309:4-6. doi: 10.1016/j.jneuroim.2017.04.004. Epub 2017 Apr 8.

PMID:
28601285
12.

Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication.

Bilger A, Plowshay J, Ma S, Nawandar D, Barlow EA, Romero-Masters JC, Bristol JA, Li Z, Tsai MH, Delecluse HJ, Kenney SC.

Oncotarget. 2017 Jul 4;8(27):44266-44280. doi: 10.18632/oncotarget.17863.

13.

Determining the IgM and IgG antibody titer against CMV and helicobacter pylori in the serum of multiple sclerosis patients comparing to the control group in Hamadan.

Salim MA, Eftekharian MM, Taheri M, Yousef Alikhani M.

Hum Antibodies. 2017 Jul 19;26(1):23-28. doi: 10.3233/HAB-170317.

PMID:
28505965
14.

[Endogenous retroviral sequences in the human genome can play a physiological or pathological role].

Medina J, Charvet B, Leblanc P, Germi R, Horvat B, Marche PN, Perron H.

Med Sci (Paris). 2017 Apr;33(4):397-403. doi: 10.1051/medsci/20173304009. Epub 2017 May 12. Review. French.

15.

UNUSUAL MANIFESTATION OF NEUROBORELIOSIS (CASE REPORT).

Beridze M, Khizanishvili N, Mdivani M, Samushia O, Gogokhia N.

Georgian Med News. 2017 Mar;(264):72-75.

PMID:
28480854
16.

Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation.

Vanheusden M, Broux B, Welten SPM, Peeters LM, Panagioti E, Van Wijmeersch B, Somers V, Stinissen P, Arens R, Hellings N.

Sci Rep. 2017 Apr 6;7(1):663. doi: 10.1038/s41598-017-00645-3.

17.

Severe Cytomegalovirus Gastritis During Natalizumab-Mediated Immunosuppression.

Persaud SP, Hassan A, Hassan A, Hassan T.

ACG Case Rep J. 2017 Mar 15;4:e43. doi: 10.14309/crj.2017.43. eCollection 2017.

18.

Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab.

Clerico M, De Mercanti S, Artusi CA, Durelli L, Naismith RT.

Mult Scler. 2017 May;23(6):874-876. doi: 10.1177/1352458516688350. Epub 2017 Feb 1.

PMID:
28290755
19.

Opportunistic infections after alemtuzumab: New cases of norcardial infection and cytomegalovirus syndrome.

Brownlee WJ, Chataway J.

Mult Scler. 2017 May;23(6):876-877. doi: 10.1177/1352458517693440. Epub 2017 Feb 1. No abstract available.

PMID:
28290753
20.

Murine Cytomegalovirus Infection Induces Susceptibility to EAE in Resistant BALB/c Mice.

Milovanovic J, Popovic B, Milovanovic M, Kvestak D, Arsenijevic A, Stojanovic B, Tanaskovic I, Krmpotic A, Arsenijevic N, Jonjic S, Lukic ML.

Front Immunol. 2017 Feb 27;8:192. doi: 10.3389/fimmu.2017.00192. eCollection 2017.

Supplemental Content

Loading ...
Support Center